LSE:HIK (Hikma Pharmaceuticals PLC)
About HIK
Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The majority of Hikmas operations are in the United States, the Middle East and North Africa Region and Europe.
Hikma Pharmaceuticals PLC (LSE: HIK) Latest News

Investing Articles
Can this FTSE 100 stock grow 2x in 2 years?

Investing Articles
Is the Hikma Pharmaceuticals share price becoming cheap?

Investing Articles
Is this FTSE pharma stock a no-brainer buy?

Investing Articles
I’d buy 2,430 shares of this stock for £100 in monthly passive income

Investing Articles
2 UK dividend stocks I’d buy today

Investing Articles
2 stocks ready to bounce back

Investing Articles
The FTSE 100 is near its lowest in a year! I’d buy these shares now

Investing Articles
Best British shares to buy in September
Investing Articles
FTSE 100 reshuffle: 2 shares I’d buy in September

Investing Articles
What are the top FTSE 100 dividend shares to buy now?

Page
Investing in Healthcare: Top UK Healthcare Stocks of 2023
